PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast
by PVI, PeerView Institute for Medical Education
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇧🇷BR · Science#5210K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
3K to 9K🎙 Daily cadence·114 episodes·Last published yesterday - Monthly Reach
Unique listeners across all episodes (30 days)
10K to 30K🇧🇷100% - Active Followers
Loyal subscribers who consistently listen
3K to 9K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 15 epsHosts
Not detected.
Recent guests
Recent episodes
Joseph K. Han, MD, FARS, FAAAAI / Anju T. Peters, MD, MS - Collaborative Approaches to Biologic Therapy in CRSwNP: Connected Systems, Better Care
Aug 31, 2026
Unknown duration
Philip J. Mease, MD, MACR - Breaking the Burden of Systemic Lupus Erythematosus: Patient Testimonials and Interprofessional Perspectives on New Developments With CAR-T Cell Therapy
Jul 13, 2026
53m 04s
Neelam Goyal, MD / Gil I. Wolfe, MD, FAAN - Spotlight on Seronegative Generalized Myasthenia Gravis: From Clinical Uncertainty to Personalized Treatment
Jul 8, 2026
47m 19s
Jiwon Oh, MD, PhD, FRCPC, Gregory F. Wu, MD, PhD, FAAN - New Pathways, New Possibilities in Multiple Sclerosis: BTK Inhibition and the Future of Patient Care
Jul 2, 2026
58m 11s
Bhavana Pothuri, MD, MS / Premal Thaker, MD, MS - Targeting With Precision in Advanced Ovarian Cancer: Integrating Approved and Novel Agents Into Personalized Treatment Plans
May 29, 2026
51m 15s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 8/31/26 | Joseph K. Han, MD, FARS, FAAAAI / Anju T. Peters, MD, MS - Collaborative Approaches to Biologic Therapy in CRSwNP: Connected Systems, Better Care | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/JYY865. CME/MOC/CC/NCPD/CPE/AAPA/IPCE credit will be available until August 23, 2027.Collaborative Approaches to Biologic Therapy in CRSwNP: Connected Systems, Better Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 7/13/26 | Systemic Lupus ErythematosusCAR-T Cell Therapy+3 | Philip J. Mease, MD, MACR | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Systemic Lupus ErythematosusCAR-T Cell Therapy+3 | Alnylam Pharmaceuticals, Inc. | 53m 04s | ||
| 7/8/26 | Seronegative Generalized Myasthenia GravisPersonalized Treatment+3 | Neelam Goyal, MDGil I. Wolfe, MD, FAAN | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Myasthenia GravisCME+3 | argenx US, Inc. | 47m 19s | ||
| 7/2/26 | Multiple SclerosisBTK Inhibition+3 | Jiwon Oh, MD, PhD, FRCPCGregory F. Wu, MD, PhD, FAAN | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+3 | — | Multiple SclerosisBTK Inhibition+5 | Genentech | 58m 11s | ||
| 5/29/26 | advanced ovarian cancerpersonalized treatment plans+3 | Bhavana Pothuri, MD, MSPremal Thaker, MD, MS | PVI, PeerView Institute for Medical EducationNational Ovarian Cancer Coalition | — | ovarian cancertargeted therapy+3 | GSK | 51m 15s | ||
| 5/29/26 | Chronic Spontaneous UrticariaHealthcare Education+3 | Adam Friedman, MD, FAAD | University of CincinnatiAccreditation Council for Continuing Medical Education (ACCME)+1 | — | Chronic Spontaneous UrticariaCME+3 | Novartis Pharmaceuticals Corporation | 55m 16s | ||
| 5/7/26 | RSVvaccine access+3 | Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPHRichard Dang, PharmD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | RSVvaccine+5 | GSK | 59m 54s | ||
| 5/7/26 | psoriasis careoral IL-23 inhibitors+3 | April W. Armstrong, MD, MPH | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | psoriasisIL-23 inhibitors+3 | Johnson & Johnson | 33m 41s | ||
| 4/27/26 | Hemophilia BGene Therapy+3 | Guy Young, MD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Hemophilia BGene Therapy+3 | CSL Behring | 53m 29s | ||
| 4/15/26 | cellular therapyNHL+3 | Olalekan Oluwole, MBBS, MPH | PeerView Institute for Medical Education | — | NHLcellular therapy+3 | Bristol Myers Squibb | 1h 00m 56s | ||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 4/15/26 | hemoglobinopathiesgene therapy+4 | Haydar Frangoul, MD, MSAkshay Sharma, MBBS, MSc | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | hemoglobinopathiesgene therapy+5 | Beam Therapeutics | 52m 16s | ||
| 3/24/26 | Psoriatic ArthritisTYK2 Inhibition+3 | Philip J. Mease, MD, MACR | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Psoriatic ArthritisTYK2 Inhibition+3 | Bristol Myers Squibb | 51m 14s | ||
| 3/4/26 | Eosinophilic EsophagitisPediatric Care+3 | Seema S. Aceves, MD, PhD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | Eosinophilic Esophagitishealthcare professionals+4 | Regeneron Pharmaceuticals, Inc | 29m 09s | ||
| 2/24/26 | CRSwNPtargeted biologic therapy+3 | Anju T. Peters, MD, MSMichael Platt, MD, MSc | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | CRSwNPbiologic therapy+3 | Regeneron Pharmaceuticals, Inc | 56m 10s | ||
| 12/29/25 | Sjögren’s DiseaseB-Cell–Mediated Pathways+3 | Thomas Grader-Beck, MD | University of CincinnatiAccreditation Council for Continuing Medical Education (ACCME)+1 | — | Sjögren’s DiseaseB-Cell+5 | Novartis Pharmaceuticals Corporation | 1h 12m 13s | ||
| 12/18/25 | CRSwNP managementbiologic therapies+3 | Joseph K. Han, MD, FARS, FAAAAI | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | CRSwNPbiologic therapies+3 | AstraZeneca Pharmaceuticals | 1h 00m 44s | ||
| 12/12/25 | Christine Franzese, MD, FARS, Flavia C.L. Hoyte, MD, FACAAI - The Type 2 Inflammation Connection in CRSwNP: Optimizing Patient Identification and Targeted Treatments | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/MNA865. CME/MOC/CC/AAPA credit will be available until November 18, 2026.The Type 2 Inflammation Connection in CRSwNP: Optimizing Patient Identification and Targeted Treatments In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 10/30/25 | Nikhil I. Khushalani, MD - The Immunotherapy Story Continues for CSCC: Insights and Evidence on Advances in Resectable and Unresectable Disease | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA information, and to apply for credit, please visit us at PeerView.com/CPY865. CME/AAPA credit will be available until October 20, 2026.The Immunotherapy Story Continues for CSCC: Insights and Evidence on Advances in Resectable and Unresectable Disease In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 10/27/25 | Aleena Banerji, MD - Improving the Care of Hereditary Angioedema: Maximizing Protection With Long-Term Prophylaxis | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/SPC865. CME/MOC/AAPA credit will be available until October 15, 2026.Improving the Care of Patients With Hereditary Angioedema: Maximizing Protection With Long-Term Prophylaxis In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Ionis Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 10/27/25 | Alexis Ogdie, MD, MSCE, Robert H. Eckel, MD, FAHA, FACC - Tackling Obesity in Psoriatic Arthritis: Key to Better Outcomes and Overall Health | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/CKQ865. CME/AAPA/IPCE credit will be available until October 23, 2026.Tackling Obesity in Psoriatic Arthritis: Key to Better Outcomes and Overall Health In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Lilly.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 9/26/25 | Kathleen M. Buchheit, MD, Joseph K. Han, MD, FARS, FAAAAI - Navigating Biologic Therapy in CRSwNP: From Patient Selection to Response Assessment | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/CC/AAPA information, and to apply for credit, please visit us at PeerView.com/FVW865. CME/MOC/CC/AAPA credit will be available until September 28, 2026.Navigating Biologic Therapy in CRSwNP: From Patient Selection to Response Assessment In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 9/26/25 | Jennifer Hsiao, MD - Don’t Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel Agents | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZU865. CME credit will be available until September 15, 2026.Don’t Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel AgentsPurdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 7/11/25 | Jacob Sands, MD - Tailwinds of Innovation in SCLC: Exploring the Therapeutic Potential of ADCs | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/XDB865. CME credit will be available until June 26, 2026.Tailwinds of Innovation in SCLC: Exploring the Therapeutic Potential of ADCs In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Daiichi Sankyo, Inc.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 7/7/25 | Joshua Sabari, MD - Precision Matters in NSCLC: Everything You Need to Know About Biomarker Testing and Targeted Therapies | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/ZEV865. CME/MOC/AAPA credit will be available until June 30, 2026.Precision Matters in NSCLC: Everything You Need to Know About Biomarker Testing and Targeted Therapies In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation, ONC Brothers. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by independent educational grants from AbbVie, AstraZeneca, Johnson & Johnson, Lilly, Nuvalent, Nuvation Bio, and Rigel Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation. | — | ||||||
| 6/30/25 | Tina Cascone, MD, PhD / Heather A. Wakelee, MD, FASCO - Strategies for Immunotherapy Success in NSCLC: How to Incorporate Modern ICI Platforms Across the Disease Continuum | This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/AWM865. CME/MOC/AAPA credit will be available until June 30, 2026.Strategies for Immunotherapy Success in NSCLC: How to Incorporate Modern ICI Platforms Across the Disease Continuum In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from Bristol Myers Squibb, Merck & Co., Inc., Rahway, NJ, USA, and Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation. | — | ||||||
Showing 25 of 123
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for PeerView Immunology & Transplantation CME/CNE/CPE Audio Podcast
Peaked at #52 in Brazil, currently #52 in Brazil.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| Brazil | — | #52 | #52 | — |
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.